Guillaume Pare Selected Research

Guillaume Pare Research Topics

Disease

12	Stroke (Strokes) 05/2022 - 05/2008
11	Opioid-Related Disorders (Opiate Addiction) 01/2017 - 01/2014
7	Myocardial Infarction 11/2020 - 05/2008
7	Substance-Related Disorders (Drug Abuse) 01/2020 - 01/2014
6	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020 - 04/2007
5	Ischemic Stroke 05/2022 - 08/2016
4	Hypertension (High Blood Pressure) 01/2022 - 04/2009
4	Embolic Stroke 01/2020 - 09/2016
4	Pain (Aches) 04/2015 - 01/2014
3	Hemorrhage 01/2021 - 06/2018
3	Acute Coronary Syndrome 01/2021 - 11/2016
3	Coronary Disease (Coronary Heart Disease) 11/2020 - 01/2017
3	Type 2 Diabetes Mellitus (MODY) 10/2019 - 01/2012
3	Chronic Pain 04/2015 - 01/2014
2	Thrombosis (Thrombus) 11/2020 - 05/2008
2	Mental Disorders (Mental Disorder) 01/2020 - 01/2015
2	Cardiovascular Diseases (Cardiovascular Disease) 03/2019 - 01/2013
2	Embolism (Embolus) 06/2018 - 09/2016
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2017 - 11/2016
2	Angioedema 09/2013 - 09/2013
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2013 - 05/2008
2	Neoplasms (Cancer) 07/2012 - 07/2012
2	Insulin Resistance 01/2012 - 05/2008
1	Dementia (Dementias) 01/2022
1	Cognitive Dysfunction 01/2022
1	Kidney Diseases (Kidney Disease) 01/2022
1	Chronic Renal Insufficiency 01/2022
1	Frailty 01/2021
1	Atherosclerotic Plaque (Atheroma) 11/2020
1	Rupture 11/2020
1	Critical Illness (Critically Ill) 09/2020
1	COVID-19 09/2020
1	Opiate Overdose 01/2020
1	Pathologic Constriction (Stenosis) 06/2018
1	Intracranial Embolism 06/2018
1	Arrhythmogenic Right Ventricular Dysplasia (Arrhythmogenic Right Ventricular Cardiomyopathy) 04/2017
1	Neuroferritinopathy 03/2017
1	Hemochromatosis (Bronze Diabetes) 03/2017
1	Iron Overload 03/2017
1	ATR-X syndrome 01/2017

Drug/Important Bio-Agent (IBA)

11	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2008
11	Opioid Analgesics (Opioids)IBA 01/2020 - 01/2014
10	Methadone (Dolophine)FDA LinkGeneric 01/2017 - 01/2014
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2008
5	Pharmaceutical PreparationsIBA 10/2019 - 09/2013
4	RivaroxabanIBA 01/2020 - 09/2016
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2020 - 09/2016
3	ApolipoproteinsIBA 05/2022 - 05/2008
3	LipidsIBA 05/2022 - 01/2013
3	C-Reactive ProteinIBA 01/2020 - 05/2008
3	Troponin T (Troponin T1)IBA 01/2020 - 03/2014
3	TroponinIBA 02/2017 - 03/2014
3	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 02/2010
3	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 01/2017 - 01/2014
2	Apolipoproteins B (ApoB)IBA 05/2022 - 08/2016
2	factor V LeidenIBA 01/2021 - 11/2020
2	ORALIT (ORS)IBA 07/2020 - 10/2019
2	Lipoprotein(a)IBA 05/2019 - 03/2019
2	Factor Xa InhibitorsIBA 06/2018 - 09/2016
2	Factor Xa (Coagulation Factor Xa)IBA 06/2018 - 09/2016
2	LDL CholesterolIBA 01/2017 - 08/2010
2	Clopidogrel (Plavix)FDA Link 11/2016 - 11/2012
2	Biological ProductsIBA 09/2016 - 01/2015
2	Testosterone (Sustanon)FDA Link 04/2015 - 08/2014
2	Ramipril (Altace)FDA LinkGeneric 01/2014 - 09/2013
2	Telmisartan (Micardis)FDA Link 01/2014 - 09/2013
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 09/2013 - 09/2013
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 09/2013 - 09/2013
2	HomocysteineIBA 09/2013 - 04/2009
2	HDL CholesterolIBA 08/2010 - 04/2007
1	Lipoproteins (Lipoprotein)IBA 05/2022
1	oxidized low density lipoproteinIBA 05/2022
1	Insulin Glargine (Lantus)FDA Link 01/2022
1	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 01/2022
1	Growth Hormone (Somatotropin)IBA 01/2022
1	UromodulinIBA 01/2022
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2021
1	InterleukinsIBA 09/2020
1	ChemokinesIBA 09/2020
1	ProteomeIBA 09/2020
1	CollagenIBA 07/2020
1	trans-crotonin (CTN)IBA 01/2020
1	AnticoagulantsIBA 06/2018
1	Cadherins (E-Cadherin)IBA 04/2017
1	IronIBA 03/2017
1	Transferrin (beta 2 Transferrin)IBA 03/2017
1	Ferritins (Ferritin)IBA 03/2017
1	ApoferritinsIBA 03/2017
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2017
1	ChromatinIBA 01/2017
1	PCSK9 InhibitorsIBA 01/2017
1	Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA 01/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017
1	Insulin (Novolin)FDA Link 01/2017
1	Blood Glucose (Blood Sugar)IBA 01/2017
1	Hemoglobins (Hemoglobin)IBA 01/2017

Therapy/Procedure

8	Therapeutics 01/2021 - 07/2012
2	Precision Medicine 01/2021 - 09/2013
2	Secondary Prevention 01/2020 - 09/2016
2	Opiate Substitution Treatment 04/2015 - 09/2014